Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hsu, Yung Ho ^a   Chen, Yen Cheng ^b   Chen, Tso Hsiao ^b   Sue, Yuh Mou ^b   Cheng, Tzu Hurng ^c   Chen, Jia Rung ^a   Chen, Cheng Hsien ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE B; PROTEIN P58; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; VASCULOTROPIN; WORTMANNIN; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; ONCOPROTEIN; VASCULOTROPIN A; ZBTB16 PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FAR INFRARED THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THERMAL ANALYSIS; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ACTIVE TRANSPORT; CELL CULTURE; CELL NUCLEUS; DOWN REGULATION; DRUG EFFECT; EVALUATION; INFRARED RADIATION; METABOLISM; METHODOLOGY; PHOTOTHERAPY; PHYSIOLOGY; PROTEIN TRANSPORT; RADIATION EXPOSURE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFRARED RAYS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOTOTHERAPY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856103745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030674     Document Type: Article

References (30)

1. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, et al. (2001) Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 38: 1083-1088.
2. Ikeda Y, Biro S, Kamogawa Y, Yoshifuku S, Eto H, et al. (2005) Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. Circ J 69: 722-729.
3. Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, et al. (2004) Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 68: 1146-1151.
4. Akasaki Y, Miyata M, Eto H, Shirasawa T, Hamada N, et al. (2006) Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia. Circ J 70: 463-470.
5. Yu SY, Chiu JH, Yang SD, Hsu YC, Lui WY, et al. (2006) Biological effect of far-infrared therapy on increasing skin microcirculation in rats. Photodermatol Photoimmunol Photomed 22: 78-86.
6. Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, et al. (2007) Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol 18: 985-992.
7. Roy-Chaudhury P, Sukhatme VP, Cheung AK, (2006) Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127.
8. Rekhter M, Nicholls S, Ferguson M, Gordon D, (1993) Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 13: 609-617.
9. Wang Y, Krishnamoorthy M, Banerjee R, Zhang J, Rudich S, et al. (2008) Venous stenosis in a pig arteriovenous fistula model-natomy, mechanisms and cellular phenotypes. Nephrol Dial Transplant 23: 525-533.
10. Schwartz SM, deBlois D, O'Brien ER, (1995) The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465.
11. Sukhatme VP, (1996) Vascular access stenosis: prospects for prevention and therapy. Kidney Int 49: 1161-1174.
12. Couper LL, Bryant SR, Eldrup-Jorgensen J, Bredenberg CE, Lindner V, (1997) Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res 81: 932-939.
13. Lindner V, Reidy MA, (1991) Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A 88: 3739-3743.
14. Guarda E, Katwa LC, Campbell SE, Tanner MA, Webel RM, et al. (1996) Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty. J Mol Cell Cardiol 28: 699-706.
15. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW, (1992) Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89: 507-511.
16. Misra S, Fu AA, Puggioni A, Karimi KM, Mandrekar JN, et al. (2008) Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294: H2219-2230.
17. Cheng TH, Leung YM, Cheung CW, Chen CH, Chen YL, et al. (2009) Propofol Depresses Angiotensin II-induced Cell Proliferation in Rat Cardiac Fibroblasts. Anesthesiology.
18. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E Jr, et al. (2003) A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 22: 6471-6482.
19. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, et al. (1993) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12: 1161-1167.
20. Melnick A, Licht JD, (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215.
21. Costoya JA, Pandolfi PP, (2001) The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. Curr Opin Hematol 8: 212-217.
22. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, et al. (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99: 1355-1366.
23. Rubbo H, O'Donnell V, (2005) Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology 208: 305-317.
24. Forstermann U, (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459: 923-939.
25. Bouloumie A, Schini-Kerth VB, Busse R, (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41: 773-780.
26. Rubbo H, Trostchansky A, O'Donnell VB, (2009) Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences. Arch Biochem Biophys 484: 167-172.
27. Virag L, Szabo E, Gergely P, Szabo C, (2003) Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 140-141: 113-124.
28. Agbani E, Coats P, Wadsworth RM, (2011) Threshold of peroxynitrite cytotoxicity in bovine pulmonary artery endothelial and smooth muscle cells. Toxicol In Vitro.
29. Rosselli M, Keller PJ, Dubey RK, (1998) Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update 4: 3-24.
30. Rush JW, Denniss SG, Graham DA, (2005) Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol 30: 442-474.